Wadih Arap
Wadih Arap
Professor of Medicine
Verified email at salud.unm.edu - Homepage
TitleCited byYear
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
W Arap, R Pasqualini, E Ruoslahti
Science 279 (5349), 377-380, 1998
Anti-cancer activity of targeted pro-apoptotic peptides
HM Ellerby, W Arap, LM Ellerby, R Kain, R Andrusiak, G Del Rio, ...
Nature medicine 5 (9), 1032, 1999
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis
R Pasqualini, E Koivunen, R Kain, J Lahdenranta, M Sakamoto, A Stryhn, ...
Cancer research 60 (3), 722-727, 2000
A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial …
DO Traktuev, S Merfeld-Clauss, J Li, M Kolonin, W Arap, R Pasqualini, ...
Circulation research 102 (1), 77-85, 2008
Steps toward mapping the human vasculature by phage display
W Arap, MG Kolonin, M Trepel, J Lahdenranta, M Cardó-Vila, ...
Nature medicine 8 (2), 121, 2002
Tumor targeting with a selective gelatinase inhibitor
E Koivunen, W Arap, H Valtanen, A Rainisalo, OP Medina, P Heikkilä, ...
Nature biotechnology 17 (8), 768, 1999
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
D Rajotte, W Arap, M Hagedorn, E Koivunen, R Pasqualini, E Ruoslahti
The Journal of clinical investigation 102 (2), 430-437, 1998
Reversal of obesity by targeted ablation of adipose tissue
MG Kolonin, PK Saha, L Chan, R Pasqualini, W Arap
Nature medicine 10 (6), 625, 2004
Intravascular delivery of particulate systems: does geometry really matter?
P Decuzzi, R Pasqualini, W Arap, M Ferrari
Pharmaceutical research 26 (1), 235, 2009
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
SY Cheng, HJ Huang, M Nagane, XD Ji, D Wang, CC Shih, W Arap, ...
Proceedings of the National Academy of Sciences 93 (16), 8502-8507, 1996
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands
MA Arap, J Lahdenranta, PJ Mintz, A Hajitou, ÁS Sarkis, W Arap, ...
Cancer cell 6 (3), 275-284, 2004
Fingerprinting the circulating repertoire of antibodies from cancer patients
PJ Mintz, J Kim, KA Do, X Wang, RG Zinner, M Cristofanilli, MA Arap, ...
Nature biotechnology 21 (1), 57, 2003
Targeting the prostate for destruction through a vascular address
W Arap, W Haedicke, M Bernasconi, R Kain, D Rajotte, S Krajewski, ...
Proceedings of the National Academy of Sciences 99 (3), 1527-1531, 2002
Three-dimensional tissue culture based on magnetic cell levitation
GR Souza, JR Molina, RM Raphael, MG Ozawa, DJ Stark, CS Levin, ...
Nature nanotechnology 5 (4), 291, 2010
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors
OJ Müller, F Kaul, MD Weitzman, R Pasqualini, W Arap, JA Kleinschmidt, ...
Nature biotechnology 21 (9), 1040, 2003
Display technologies: application for the discovery of drug and gene delivery agents
A Sergeeva, MG Kolonin, JJ Molldrem, R Pasqualini, W Arap
Advanced drug delivery reviews 58 (15), 1622-1654, 2006
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells
F Curnis, G Arrigoni, A Sacchi, L Fischetti, W Arap, R Pasqualini, A Corti
Cancer research 62 (3), 867-874, 2002
Biopanning and rapid analysis of selective interactive ligands
RJ Giordano, M Cardó-Vila, J Lahdenranta, R Pasqualini, W Arap
Nature medicine 7 (11), 1249, 2001
CD13/APN is activated by angiogenic signals and is essential for capillary tube formation
SV Bhagwat, J Lahdenranta, R Giordano, W Arap, R Pasqualini, ...
Blood 97 (3), 652-659, 2001
Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents
GR Souza, DR Christianson, FI Staquicini, MG Ozawa, EY Snyder, ...
Proceedings of the National Academy of Sciences 103 (5), 1215-1220, 2006
The system can't perform the operation now. Try again later.
Articles 1–20